| Literature DB >> 29589964 |
Abstract
Health screening can only be applied to populations, not individuals. For it to be effective, the initial screening test must be acceptable and reasonably accurate, the disease must be treatable with better outcomes when treated early and the harm and cost associated with screening must not outweigh its benefits. Robust evidence is therefore required before systematic screening is implemented. Surveillance implies the testing of people at high risk of disease and is therefore distinct from screening in both scale (smaller) and intensity (greater). In both cases, however, clear information must be provided to potential participants so that they can weigh up the balance of benefit and harm before deciding on whether or not to engage in the process.Entities:
Mesh:
Year: 2018 PMID: 29589964 PMCID: PMC6350463 DOI: 10.1259/bjr.20180200
Source DB: PubMed Journal: Br J Radiol ISSN: 0007-1285 Impact factor: 3.039